In the rapidly evolving landscape of clinical development, IQVIA Laboratories is at the forefront of innovation, bridging the gap between pre-clinical research and early clinical trials. Our state-of-the-art Translational Science and Innovation Laboratory (TSAIL) is designed to accelerate drug development through early assay development and the adoption of emerging technologies.
Discover the Power of TSAIL:
- Accelerated Biomarker Discovery: From histopathologic diagnostics to multiplexed biomarker assessments, TSAIL ensures rapid deployment of the most effective predictive biomarkers and technologies.
- Cutting-Edge Technology Platforms: Leverage our diverse portfolio, including Cytek Aurora Spectral Flow Cytometers, Mab Tech IRIS ELISpot/FluoroSpot Readers, Thermo Fisher Genexus System, and more, to enhance your research capabilities.
- Expertise and Collaboration: Work alongside experienced biomarker development scientists, board-certified pathologists, and immunologists to overcome challenges and achieve clinical trial success.
- Holistic AI/ML Integration: Utilize artificial intelligence and machine learning for advanced whole slide imaging analytics and digital image processing.
- Comprehensive Molecular-Genetic Pathology: Access fixed tissue and liquid DNA/RNA genetic profiling, solid tumor molecular minimal residual disease analysis, and clinical variant curation.
Join us in revolutionizing the journey from biomarker discovery to clinical study assay development. Explore our new fact sheet to learn how TSAIL is transforming the future of therapeutics.
Download Document
Related Insights
Reproducibility Challenges in an era of Massive Data
Presented at the MCBIOS & MAQC 2021 Joint Conference
A Verified Genomic Reference Sample for Assessing Performance of Cancer Panels Detecting Small Variants of Low Allele Frequency
Presented at the MCBIOS & MAQC 2021 Joint Conference
Unexpected Impacts to Library Complexity After DNA and RNA Library Preparation in Illumina Next Generation Sequencing
Presented at the MCBIOS & MAQC 2021 Joint Conference
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy
Gene expression and analysis for detection of 38 Immune Landscape Signatures
Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials
Genomic technologies that empower and enhance immuno-oncology trials
Laboratory Solutions for Hepatitis B (HBV) Clinical Trials
Insight brief by Joseph Sebastian, Ph.D., Scientific Advisor, Infectious & Liver Diseases
Enabling blood sample prep for single cell sequencing in clinical research
The Role of Genomics in Clinical Trials with Patrick Hurban
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Evaluating and Implementing SARS-CoV-2 PCR Tests for Diagnostic and Clinical Trial Use
AAPS 2020 COVID-19 Workshop: Current Pharmaceutical Developments for Cures and Prevention
